ArticleCurrent oncology (Toronto, Ont.)2022

Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach.

Waleed Sabry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.